Addressing the Mental Health Crisis in Children
The pandemic made a troubling mental health trend in children much worse. What’s being done to help them?
Update on Treatment Options for Alzheimer’s
While a cure for Alzheimer’s remains elusive, new diagnostic tools and treatment options are improving patient quality of life.
Breakthroughs in Gene Therapy
Exciting new developments in gene therapy and genome editing show promise for treating a variety of genetic diseases.
Pros and Cons of Virtual Care Solutions
Do the advantages of virtual care outweigh the drawbacks? Patients seem to think so.
Novel Immunotherapies Target RSV Disease at Both Ends of the Age Spectrum
RSV infections account for a large share of U.S. hospitalizations for lower respiratory tract disease due in large part to a lack of immunization and prophylactic therapies, but new developments and cutting-edge therapies may soon become standard medical practice.
Proposed Payment Systems and Fee Schedules in 2023
Proposed rules revising the Medicare Hospital Outpatient Prospective Payment System (OPPS) and the Medicare Ambulatory Surgical Center (ASC) services, along with new physician fee schedule (PFS) rule sets will significantly impact providers in 2023.
Myths & Facts: Depression
The best way to help individuals suffering from depression is to spread awareness about the misconceptions surrounding this mood disorder.
Vaccine Passports: Vaccination Confirmation or a Privacy Concern?
The implementation of vaccine passports in response to the COVID-19 pandemic has raised arguments for and against them.
Ryplazim: The First Definitive Treatment for Congenital Plasminogen Deficiency
An ultrarare autosomal recessive disorder, congenital plasminogen deficiency (PLGD) results from inheritance of defective copies of both alleles of the PLG gene, which yields dysfunctional or too little plasminogen. The end result is impaired extracellular fibrin clearance during wound healing, presenting on affected mucous membranes throughout the body as accumulations of nondegraded fibrin as pseudomembranous ligneous — “woody” — growths.
Myths & Facts: Melanoma
While the incidence of melanoma has stabilized over the past five years, the number of people diagnosed is still alarming.
